Google DeepMind on October 15, 2026 published a technical walkthrough in which biologists used Google Antigravity, its agentic development platform, to identify a novel antimicrobial peptide candidate in Streptococcus pseudopneumoniae, and the company said the lead is undergoing wet-lab validation. The walkthrough, authored by Pengfei Tian, Maxwell L Bileschi, Zoi Tsangalidou, Sukhdeep Singh, and Lucy J. Colwell, frames the work against rising antimicrobial resistance, which the post says could…
This article has been indexed from Unite.AI
Read the original article: